CyberArk Software (CYBR)
(Delayed Data from NSDQ)
$299.98 USD
+4.33 (1.46%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $300.46 +0.48 (0.16%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$299.98 USD
+4.33 (1.46%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $300.46 +0.48 (0.16%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum D VGM
Zacks News
Are You Looking for a Top Momentum Pick? Why CyberArk (CYBR) is a Great Choice
by Zacks Equity Research
Does CyberArk (CYBR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is CyberArk Software (CYBR) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (CYBR) Outperforming Other Computer and Technology Stocks This Year?
3 Reasons Why Growth Investors Shouldn't Overlook CyberArk (CYBR)
by Zacks Equity Research
CyberArk (CYBR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Near-Term Prospects Look Encouraging for Security Industry
by Chandrima Sanyal
Concerns related to high profile data breaches and increased spending on security position the Zacks Security industry well for growth.
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys
by Zacks Equity Research
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys
Why CyberArk (CYBR) Stock Might be a Great Pick
by Zacks Equity Research
CyberArk (CYBR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
What Bargain Hunting? Tap 5 Stocks With Rising P/E
by Sanghamitra Saha
Bet on these top-ranked stocks with rising P/E for outsized gains.
Is CyberArk Software (CYBR) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (CYBR) Outperforming Other Computer and Technology Stocks This Year?
Here is Why Growth Investors Should Buy CyberArk (CYBR) Now
by Zacks Equity Research
CyberArk (CYBR) could produce exceptional returns because of its solid growth attributes.
CyberArk (CYBR) Beats on Q3 Earnings & Revenues, Lifts View
by Zacks Equity Research
CyberArk (CYBR) third-quarter 2019 earnings benefit from increased demand for privileged access security. Moreover, strong demand across energy and pharmaceutical verticals drives revenues.
CyberArk (CYBR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CyberArk (CYBR) delivered earnings and revenue surprises of 38.30% and 4.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
CyberArk (CYBR) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CyberArk's (CYBR) Q3 earnings might have gained from increasing clientele of its Privileged Account Security offering. However, high expenses are likely to have weighed on margins.
Earnings Preview: CyberArk (CYBR) Q3 Earnings Expected to Decline
by Zacks Equity Research
CyberArk (CYBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CyberArk (CYBR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CyberArk (CYBR) closed at $100.05, marking a -0.73% move from the previous day.
Has CyberArk Software (CYBR) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (CYBR) Outperforming Other Computer and Technology Stocks This Year?
CyberArk (CYBR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CyberArk (CYBR) closed at $101.94 in the latest trading session, marking a -0.17% move from the prior day.
CyberArk (CYBR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CyberArk (CYBR) closed at $104.80 in the latest trading session, marking a -0.02% move from the prior day.
Has CyberArk Software (CYBR) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (CYBR) Outperforming Other Computer and Technology Stocks This Year?
CyberArk (CYBR) Stock Moves -0.18%: What You Should Know
by Zacks Equity Research
CyberArk (CYBR) closed at $105.31 in the latest trading session, marking a -0.18% move from the prior day.
Is CyberArk Software (CYBR) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Is (CYBR) Outperforming Other Computer and Technology Stocks This Year?
CyberArk Software Enters Oversold Territory
by Zacks Equity Research
CyberArk Software Ltd. (CYBR) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
What Makes Palo Alto Networks (PANW) a Strong Sell?
by Zacks Equity Research
Palo Alto Networks (PANW) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Zacks.com featured highlights include: Zumiez, Funko, Frontdoor, CyberArk and Universal Display
by Zacks Equity Research
Zacks.com featured highlights include: Zumiez, Funko, Frontdoor, CyberArk and Universal Display
Looking to Make the Most of Earnings Beat? 5 Top Picks
by Sanghamitra Saha
Invest in top-ranked stocks that are likely to beat their earnings estimates in the upcoming releases.
The Zacks Analyst Blog Highlights: Perficient, Chegg, CyberArk, OSI and Itron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Perficient, Chegg, CyberArk, OSI and Itron